Certainly not the first generic epinephrine auto-injector in the market. Also not fair to call it a generic version of the EpiPen considering Mylan (those who make EpiPens) released their own...
Certainly not the first generic epinephrine auto-injector in the market. Also not fair to call it a generic version of the EpiPen considering Mylan (those who make EpiPens) released their own generic version which is an exact copy of their EpiPen product line, except it lacks the brand name and is less than half the cost.
I am happy to see more competition in the market, hope they begin removing some policies that have created this monopoly.
Other generic auto-injectors cannot be given to someone with a prescription for EpiPen. Mylan's generic is a therapeutic equivalent, but note that "less than half the cost" is still three times...
The new drug, from Teva Pharmaceuticals USA, is the first to be deemed a therapeutic equivalent of the EpiPen, which means that it can be automatically substituted at the pharmacy counter for prescriptions for EpiPen or EpiPen Jr.
Other generic auto-injectors cannot be given to someone with a prescription for EpiPen.
Mylan's generic is a therapeutic equivalent, but note that "less than half the cost" is still three times what the branded version cost 10 years ago when Mylan bought it from Merck.
Then Teva didn't make the first. Of course it still is ridiculous considering that the actual drug costs nothing and it's the patented auto-injector that is being sold.
Mylan's generic is a therapeutic equivalent
Then Teva didn't make the first.
"less than half the cost" is still three times what the branded version cost 10 years ago when Mylan bought it from Merck.
Of course it still is ridiculous considering that the actual drug costs nothing and it's the patented auto-injector that is being sold.
Certainly not the first generic epinephrine auto-injector in the market. Also not fair to call it a generic version of the EpiPen considering Mylan (those who make EpiPens) released their own generic version which is an exact copy of their EpiPen product line, except it lacks the brand name and is less than half the cost.
I am happy to see more competition in the market, hope they begin removing some policies that have created this monopoly.
Other generic auto-injectors cannot be given to someone with a prescription for EpiPen.
Mylan's generic is a therapeutic equivalent, but note that "less than half the cost" is still three times what the branded version cost 10 years ago when Mylan bought it from Merck.
Then Teva didn't make the first.
Of course it still is ridiculous considering that the actual drug costs nothing and it's the patented auto-injector that is being sold.